Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.


HHS - 2527 - Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria - Presidential
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NamePresidential Advisory Council on Combating Antibiotic-Resistant BacteriaAgency NameDepartment of Health and Human Services
Fiscal Year2020Committee Number2527
Original Establishment Date3/24/2015Committee StatusChartered
Actual Termination Date9/30/2019Committee URLhttps://www.hhs.gov/ash/carb
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*35
Current Charter Date9/2/2020Designated Fed Officer Position Title*DFO
Date Of Renewal Charter9/2/2022Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Jomana
Exempt From Renewal*NoDesignated Federal Officer Middle NameF
Specific Termination AuthorityDesignated Federal Officer Last Name*Musmar
Establishment Authority*PresidentialDesignated Federal Officer SuffixMS, PhD
Specific Establishment Authority*EO 13676Designated Federal Officer Phone*(202) 795-7678
Effective Date Of Authority*9/18/2014Designated Federal Officer Fax*202-690-4631
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*jomana.musmar@hhs.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNo
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Advisory Council functions as a non-discretionary federal advisory committee. It was established to provide advice, information, and recommendations to the Secretary of Health and Human Services regarding programs and policies intended to support and evaluate the implementation of Executive Order 13676, including the National Strategy for Combating Antibiotic-Resistant Bacteria (Strategy) and the National Action Plan for Combating Antibiotic-Resistant Bacteria (Action Plan). It has been continued in 2019 through Section 505 of Public Law No. 116-22, the Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAIA). The Advisory Council will meet, at a minimum, two times per fiscal year depending on the availability of funds. With approval or recommendation of the Secretary, the Advisory Council may establish standing and ad hoc subcommittees and/or working groups to provide assistance for carrying out its function. To the extent permitted by law, the agencies that comprise the Task Force for Combating Antibiotic-Resistant Bacteria shall provide the Advisory Council with such information as it may require for purposes of carrying out its function. The Advisory Council was also mandated by Pub. Law No. 116-22, the Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019, which continues the council's activities as indicated under EO 13676.
How is membership balanced?*The Advisory Council will consist of voting and non-voting members and the Chair and Vice Chair. The Secretary of Health and Human Services will appoint individuals to serve as the Advisory Council leadership. The Advisory Council leadership will be selected from among the voting members who have demonstrated ability both to lead the work of similar bodies and to work effectively in partnership with federal agencies and partner organizations. The public voting members will represent balanced points of view from human biomedical, public health, and agricultural fields to include surveillance of antibiotic-resistant infections, prevention and/or interruption of the spread of antibiotic-resistant threats, or development of rapid diagnostics and novel treatments. The public voting members may be physicians, veterinarians, epidemiologists, microbiologists, or other health care professionals (e.g., nurses, pharmacists, others); individuals who have expertise and experience as consumer or patient advocates concerned with antibiotic resistance, or in the fields of agriculture and pharmaceuticals; and they also may be from State or local health agencies or public health organizations. The Advisory Council includes non-voting regular government employees (RGEs) members who are selected to represent various federal agencies, including HHS, the Department of Defense, and the USDA, that are involved in the development, testing, licensing, production, procurement, distribution, and/or use of antibiotics and/or antibiotic research. The federal RGEs possess the knowledge, skills, experience, and expertise necessary to inform the council's recommendations with respect to the issues mandated by Executive Order 13676. Federal agencies are invited to participate as non-voting RGE members, as it is deemed necessary by the Secretary, in consultation with the Secretaries of Defense and Agriculture, to accomplish the mission of the Advisory Council.The Advisory Council structure also may include non-voting liaison representatives members from organizations and/or interests groups that have involvement in the development, testing, licensing, production, procurement, distribution, and/or use of antibiotics and/or antibiotic research. Invitations are extended to organizations to participate as non-voting liaison representative members, as it is deemed necessary by the Secretary or designee to accomplish the established mission of the Advisory Council.
How frequent & relevant are cmte mtgs?*It is stipulated in the charter that the Advisory Council will meet, at a minimum, two times per fiscal year depending on the availability of funds.The rise of antibiotic-resistant bacteria represents a serious threat to public health and the economy. Detecting, preventing, and controlling antibiotic-resistance requires a strategic, coordinated, and sustained effort. The Advisory Council will provide advice and recommendations to the Secretary of Health and Human Services to assist the federal government in its efforts to detect, prevent, and control illness and death related to antibiotic-resistant infections.
Why advice can't be obtained elsewhere?*The rise of antibiotic-resistant bacteria represents a serious threat to public health and the economy. Detecting, preventing, and controlling antibiotic resistance requires a strategic, coordinated, and sustained effort from all One Health domains--particular human and animal health. The federal government will work domestically and internationally to detect, prevent, and control illness and death related to antibiotic-resistant infections by implementing measures that reduce the emergence and spread of antibiotic-resistant bacteria and help ensure the continued availability of effective therapeutics for the treatment of bacterial infections. To this end, the President issued Executive Order 13676, dated September 18, 2014, which included authorization for the Advisory Council to be established to provide advice, information, and recommendations to the Secretary of Health and Human Services regarding programs and policies intended to support and evaluate implementation of this directive, including the National Strategy for Combating Antibiotic-Resistant Bacteria (Strategy) and the National Action Plan for Combating Antibiotic-Resistant Bacteria (Action Plan). Congress has further recognized the importance of this issue by continuing the council under statutory authority vis-à-vis the passage of PAHPAIA 2019. The Advisory Council represents the perspectives of both human and agricultural subject matter experts, exemplifying the U.S. Government’s commitment to combating this public health issue through a true One Health approach. This is the only FAC solely dedicated to the topics of Antibiotic Resistance with the diverse combination of expertise that advises the Secretary. Pandemic and All Hazards Preparedness and Advancing Innovation Act (PAHPAIA) 2019 also codified the council reflecting its importance within the context of all hazards since Antimicrobial Resistance (AMR) is now considered a public health security.
Why close or partially close meetings?Meetings of the Advisory Council will be open to the public unless information not approved for public disclosure has been given to the Advisory Council for discussion. If it becomes necessary for an Advisory Council meeting to be closed, then the guidelines established under the FACA, by GSA, and by the Department of Health and Human Services will be followed for this action to be taken.
Recommendation RemarksNo recommendations were issued by the Council for FY20.

The only annual reporting requirement that the Advisory Council must satisfy is to keep accurate the file that is maintained in the FACA database for the annual comprehensive review. There is no other requirement to provide an annual written report on the Advisory Council's activities/accomplishments.

The budget for this committee remains flat, so although estimates in different categories changed based on percentage increases in inflation, the total spent this year is somewhat static to account for the same number of in-person meetings at an estimated 2.6% increase in Federal salaries and an estimated 6%. The costs in place for consultants are also static due to the contractual obligations set forth in their contracts.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesYes
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationYes
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction Other 
Outcome Increased Customer SatisfactionYesAction Comment
Outcome Implement Laws/Reg RequirementsYesGrants Review*No
Outcome OtherYesNumber Of Grants Reviewed0
Outcome CommentThe federal government will work domestically and internationally to detect, prevent, and control illness and death related to antibiotic-resistant infections by implementing measures that reduce the emergence and spread of antibiotic-resistant bacteria and help ensure the continued availability of effective therapeutics for the treatment of bacterial infections.Number Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentNot ApplicableGrants Review CommentNot Applicable
Number Of Recommendations*133Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe Advisory Council approved their initial report with recommendations titled, Initial Assessments of the National Action Plan for Combating Antibiotic-Resistant Bacteria at the March 31, 2016 Public Meeting. The first report includes 37 individual recommendations for the Secretary of HHS. The second report with recommendations titled, Recommendations for Incentivizing the Development of Vaccines, Diagnostics, and Therapeutics to Combat Antibiotic-Resistance was approved at the September 14, 2017 Public Meeting. The second report includes 64 individual recommendations for the Secretary of HHS. The Advisory Council approved two resolution letters at the March 2, 2018 virtual Public Meeting, each containing two recommendations. The third report titled, Key Strategies to Enhance Infection Prevention and Antibiotic Stewardship, approved at the September 26, 2018, Public Meeting includes seven recommendations. The Advisory Council held a public meeting via teleconference on April 8, 2019, and approved a 1-page letter with one recommendation. The fourth full report, Priorities for the NAP on CARB 2020-2025 was voted and approved at the July 10, 2019, public meeting, and included twenty recommendations.Access Agency WebsiteYes
% of Recs Fully Implemented*50.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThe exact number of adopted recommendations remains to be determined. An estimate has been provided based on agency activity.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsYes
% of Recs Partially Implemented CommentThe number of adopted recommendations remains to be determined.Access OtherNo
Agency Feedback*Not ApplicableAccess CommentN/A
Agency Feedback Comment*Not ApplicableNarrative Description*The rise of antibiotic-resistant bacteria represents a serious threat to public health and the economy. Detecting, preventing, and controlling antibiotic resistance requires a strategic, coordinated, and sustained effort. The federal government will work domestically and internationally to detect, prevent, and control illness and death related to antibiotic-resistant infections by implementing measures that reduce the emergence and spread of antibiotic-resistant bacteria and help ensure the continued availability of effective therapeutics for the treatment of bacterial infections.On September 18, 2014, the President issued Executive Order 13676, to direct the Secretary of Health and Human Services (Secretary) to consult with the Secretaries of Defense and Agriculture to establish the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). On March 24, 2015, the Advisory Council was established as a non-discretionary federal advisory committee. On March 3, 2020, the President of the United States delegated his authority to the Secretary of Health and Human Services under section 9(a)(1) of the Federal Advisory Committee Act (FACA), Public Law 92-463, as amended (5 U.S.C. App.), to re-establish the PACCARB. Pursuant to this delegation of authority, the Secretary re-established the Advisory Council, and the charter was filed on September 2, 2020. Per the President's delegation of authority, the Secretary may direct the PACCARB to perform duties consistent with those assigned to them in section 505(b) of Public Law 116-22 (June 24, 2019), the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAIA).
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$0.00Est Payments to Non-Fed Members Next FY*$0.00
Payments to Federal Members*$708.00Est. Payments to Fed Members Next FY*$8,500.00
Payments to Federal Staff*$38,221.00Estimated Payments to Federal Staff*$458,656.00
Payments to Consultants*$24,243.00Est. Payments to Consultants Next FY*$290,926.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$0.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$27,641.00Est. Other Costs Next FY*$331,700.00
Total Costs$90,813.00Est. Total Next FY*$1,089,782.00
Federal Staff Support (FTE)*2.00Est. Fed Staff Support Next FY*3.00
Cost RemarksCouncil was officially re-established Sept 2nd at the end of FY 2020.Est Cost RemarksCouncil was terminated Sept 30, 2019 and re-established Sept 2, 2020. the estimates above are based on operations 10/01/2020 - Sept 30. 2021
Hide Section - Interest Areas

Interest Areas

Category
Area
Agriculture
Agriculture
Animals
Animal Sciences and Husbandry
Veterinary Medicine
Applied Science
Applied Sciences
Basic Science
Basic Sciences
Biology
Chemistry
Materials Research
Microbiology
Business
Industry
Manufacturing
Patents and Trademarks
Small Business
Data
Data Quality
Education
Education
Training
Emergency
Emergency Preparedness and Management
Energy
Natural Resources
Environment
Environmental Issues
Waste Disposal
Federal Employment
Public Services
Food and Drugs
Biotechnology
Food and Drugs
Medical Devices
Government
Federal Government
Internal Federal Government
State Government
Tribal Government
Health
Biodefense
Health Care
Hospitals
Medical Education
Medical Practitioners
Public Health
Safety
Treatment
International
International Organizations
Labor
Job Training
Legislation
Regulations
Rulemaking
Medicine
Diseases
Health and Health Research
Illnesses
Medicine and Dentistry
National Defense
National Security and Defense
Research
Research and Development
Science and Technology
Innovation
Science and Technology
Social Sciences
Risk Communication
Social Sciences
Trade
Exports and Imports
Veterans
Veterans and Veterans' Medical Care
Water
Water Use
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - SUBCOMMITTEES

SUBCOMMITTEES

Committee

Subcommittees

ActionCommittee System IDSubcommittee NameFiscal Year
 COM-032501Strategic Planning Working Group2020
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-036831Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria2019
 COM-034683Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria2018
 COM-001667Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria2017
 COM-002402Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria2016
 COM-004146Presidential Advisory Council on Combating Antibotic-Resistant Bacteria2015